Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, 3052, Australia.
Sci Rep. 2019 Oct 10;9(1):14626. doi: 10.1038/s41598-019-51267-w.
A single mild traumatic brain injury (mTBI) typically causes only transient symptoms, but repeated mTBI (RmTBI) is associated with cumulative and chronic neurological abnormalities. Clinical management of mTBI is challenging due to the heterogeneous, subjective and transient nature of symptoms, and thus would be aided by objective biomarkers. Promising biomarkers including advanced magnetic resonance imaging (MRI) and plasma levels of select proteins were examined here in a rat model of RmTBI. Rats received either two mild fluid percussion or sham injuries administered five days apart. Rats underwent MRI and behavioral testing 1, 3, 5, 7, and 30 days after the second injury and blood samples were collected on days 1, 7, and 30. Structural and diffusion-weighted MRI revealed that RmTBI rats had abnormalities in the cortex and corpus callosum. Proteomic analysis of plasma found that RmTBI rats had abnormalities in markers indicating axonal and vascular injury, metabolic and mitochondrial dysfunction, and glial reactivity. These changes occurred in the presence of ongoing cognitive and sensorimotor deficits in the RmTBI rats. Our findings demonstrate that RmTBI can result in chronic neurological abnormalities, provide insight into potential contributing pathophysiological mechanisms, and supports the use of MRI and plasma protein measures as RmTBI biomarkers.
单次轻度创伤性脑损伤(mTBI)通常只会导致短暂的症状,但重复 mTBI(RmTBI)与累积和慢性神经异常有关。由于症状的异质性、主观性和短暂性,mTBI 的临床管理具有挑战性,因此需要客观的生物标志物来辅助。在此,我们在 RmTBI 的大鼠模型中检查了包括先进的磁共振成像(MRI)和选定蛋白质的血浆水平在内的有前途的生物标志物。大鼠接受两次轻度液压冲击或假损伤,间隔五天。大鼠在第二次损伤后 1、3、5、7 和 30 天进行 MRI 和行为测试,并在第 1、7 和 30 天采集血液样本。结构和扩散加权 MRI 显示 RmTBI 大鼠的皮质和胼胝体有异常。对血浆的蛋白质组学分析发现,RmTBI 大鼠的标志物表明轴突和血管损伤、代谢和线粒体功能障碍以及神经胶质反应有异常。这些变化发生在 RmTBI 大鼠持续存在认知和感觉运动缺陷的情况下。我们的研究结果表明,RmTBI 可导致慢性神经异常,深入了解潜在的致病生理机制,并支持使用 MRI 和血浆蛋白测量作为 RmTBI 的生物标志物。